InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.060
-0.040 (-3.64%)
Dec 5, 2025, 4:00 PM EST - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023
Period Ending
Dec '24 Dec '23
Novel Therapeutic Products
179.33K
Log In
Novel Therapeutic Products Growth
162.93%
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023
Period Ending
Dec '24 Dec '23
United States
179.33K
Log In
United States Growth
162.93%
Log In